Clinical Applications of Ferric Sulfate in Dentistry: A Narrative Review
Clinical Applications of Ferric Sulfate in Dentistry: A Narrative Review
Clinical Applications of Ferric Sulfate in Dentistry: A Narrative Review
144]
Review Article
Abstract
Ferric sulfate (FS) has been commonly used as a local hemostatic agent for more than three decades in dentistry. Even though
the hemostatic mechanism of FS is questioned, it seems that agglutination of blood proteins occurs due to the reaction of blood
with ferric and sulfate ions in acidic pH. FS has gained widespread importance as a pulpotomy medicament in contemporary
dentistry; nevertheless, it has several applications in different fields of dentistry which was paid little attention. Hence, the
purpose of this paper is to review the various applications of FS in dentistry, along with restorative dentistry and endodontics.
Keywords: Applications; dentistry; ferric sulfate; hemostasis
Table 1: Commercial forms of ferric sulfate available mutans, Streptococcus sobrinus, and Aggregatibacter
and their concentration actinomycetemcomitans under in vitro condition.[20] This
Commercial form Concentration of ferric might be due to its acidic pH[4] and cytotoxicity.[5] In
sulfate (%) addition, the occlusion of capillary orifices by agglutinated
ViscoStat® (Ultradent products, Inc, 20 proteins prevents the ingress of bacteria.[20]
South Jordan, UT)[2]
Astringedent® (Ultradent products, Inc., 15.5
Salt Lake City, UT)[12‑14] During restorative procedures
Astringedent® X (Ultradent products, Inc, 12.7 FS in a concentration of 15.5%–20%[21] is one of the most
South Jordan, UT) common chemical hemostatic reagents used in the
Stasis® (Belport Co, Camarillo, CA, 21
USA)[15] restorative dentistry.[22‑24] It is chemically impregnated into
retraction cords in chemomechanical gingival retraction
technique in which FS is used in 15%–25% concentration
APPLICATIONS OF FERRIC SULFATE IN for 3–10 min[24] and offers greater sulcus displacement due
DENTISTRY to combined physical and chemical effect.[21] Nevertheless,
high acidity of gingival retraction fluids and the high
Pulpotomy medicament affinity of ferric ions for hard tooth structures results in the
FS has been commonly used as a pulpotomy medicament interaction with bacterial byproducts and precipitation of
to control pulpal bleeding in vital pulp therapy since insoluble ferric sulfide in the porous demineralized dentin.
three decades. It induces hemostasis by forming a sealing This is the reason for internal discoloration of the dentin.
membrane at the damaged vessels of pulpal tissue by Conrad and Holtan[25] observed that use of FS gingival
agglutinating the blood proteins with ferric and sulfate retraction fluid in combination with translucent porcelain
ions.[12] restorations resulted in black internal discoloration of the
dentin under porcelain crowns.
The nonaldehyde form of FS is most preferred as a
pulpotomy agent due to its mechanism of controlling Dentinal exposure to such highly acidic solutions of
hemorrhage, believed to be associated with physiological FS (pH range of 0.7–2.0), for 30 s, results in rapid removal
clot formation. This might minimize the chances of of superficial smear layer and peritubular dentin was
inflammation and internal resorption when placed on the also lost after prolonged exposure.[26] Furthermore,
amputated pulp tissue for 5 min.[16,17] removal of smear layer by hemostatic agents has been
suggested to negatively affect the bonding mechanism
The most important form of FS is minimal devitalization of self‑etching adhesive,[25,27] which may further promote
and preservation of the pulp tissue.[13] The metal‑protein marginal microleakage and discoloration.[28] Hence, cavity
clot at the surface of the amputated pulp stumps may disinfection‑associated resin composite restorations is
probably act as a barrier to the irritative components of the material specific.[29] Cohesive failures were observed in
sub‑base and functions exclusively in a passive manner.[18] primary dentin bonded with self‑etch adhesive systems
FS showed superior quality of minimizing inflammation after application of FS.[30] Ebrahimi et al.[31] observed
and internal resorption compared to calcium hydroxide that dentin surfaces contaminated with ViscoStat® for
because of physiological clot formation by the agglutinated 60 s before applying adhesives showed reduced shear
proteins.[5,16] bond strength of adhesive to dentin. Most of the failures
observed were adhesive.
Landau and Johnsen[19] reported the application of FS as
a pulpotomy medicament in monkey teeth. Fei et al.[12] To achieve better outcomes during impression making
published the first human clinical trial using FS with 100% or application of bonding agents, the hemostatic agents
clinical success, compared to formocresol (77%) with applied before or during etching should be rinsed off
1‑year follow‑up. Similarly, Fuks et al.[13] reported a study properly to create a dentin smear layer. However, rinsing
employing FS showing high radiographic success rate of alone cannot eliminate surfaces contamination and thus
74.5%. the remnant FS interfered with diffusion of adhesive in
dentinal tubules.[31,32] Because of the weak acidity of the
Antibacterial agent primer in self‑etch adhesives, they could not dissolve the
FS not only exhibited hemostatic action but also has contamination by ViscoStat®;[33] hence, it is impossible to
antimicrobial activity. Antibacterial efficacy of FS is penetrate deeper into dentin.[32] The suggested mechanism
similar to 0.2% chlorhexidine digluconate but better than was that hemostatic agent causes derangement in bonding
Ankaferd blood stopper® on oral microorganisms such procedure because of dentinal tubules obturation and
as Staphylococcus aureus, Enterococcus faecalis, Candida dentinal surface was demineralized in different values.[28]
albicans, Candida albicans, Porphyromonas gingivalis, It is preferably recommended that FS should be used with
Lactobacillus acidophilus, Lactobacillus salivarius, Streptococcus etch‑and‑rinse adhesive systems only.[24] Use of self‑etching
adhesive significantly lowered the bond strength of dentin Table 2: Merits and demerits of ferric sulphate
contaminated with the hemostatic agent compared to Merits Demerits
normal dentin. Kuphasuck et al.[28] found that the hemostatic Adequate hemostasis Tissue discoloration
agent does not have any effect on dentin bond strength of Reversible inflammatory Acidic taste
response in oral soft tissues Risk of sulcus contamination
the total‑etching adhesive.
Cost effective and less time Inhibits set of polyvinyl siloxane and
consuming polyether Impressions
For gingival displacement in prosthodontics Stops bleeding in seconds, Reduces the bond strength of
Fischer (1987) first used FS as a coagulative and hemostatic saving chair time adhesives
Decrease costly impression Causes microleakage under
agent during crown and bridge impressions.[4] It is used for remakes restorations
tissue displacement and it would be maintained for at least Effective and easy to use for
30 min.[4,14] Nonetheless, its use for gingival displacement control of bleeding, tissue
management, and pulpotomies
in implantology is not clearly understood as a result of its
ability to interrupt the setting reaction of polyether and
polyvinyl siloxane impression materials.[25,34] Owing to its An intense inflammatory response including foreign
iron content, FS stains the gingival tissue yellow‑brown body reaction and delayed osseous healing was
to black color for a few days after its application. It has documented histologically after 18 and 46 days, when
been shown to interfere with surface details of impression FS was left in situ for maximum exposure.[5] However,
materials, as well as discolor dentin by precipitating when adequately curetted and irrigated from the
ferric sulfide in an anaerobic environment.[25] Irrigation surgical site before closure, FS neither causes persistent
with water for at least 10 s eliminates the staining and inflammation nor delays osseous repair.[41] Adequate
discoloration effect of ferric compounds on gingiva and hemostasis can be achieved following the application
esthetic restorations. Furthermore, two studies reported of 20% FS (Viscostat®) for 5 s during the endodontic
that chlorhexidine gluconate helps achieve hemostasis surgeries such as root‑end resection, root‑end
in a shorter time due to its surfactant effect.[34,35] Shaw preparation, and root‑end filling.[2]
et al.[36] observed reversible damage to the connective
tissue adjacent to the sulcular gingiva after application Merits and demerits
of FS. Nevertheless, when used within the gingival sulcus FS has several merits and a few demerits, which are shown
for <10 min, they cause minimal tissue damage.[21‑23] in Table 2.[4,8,9,12,25,28,31]
2. Vickers FJ, Baumgartner JC, Marshall G. Hemostatic efficacy and 22. Morgano SM, Malone WF, Gregoire SE, Goldenberg BS. Tissue
cardiovascular effects of agents used during endodontic surgery. management with dental impression materials. Am J Dent 1989;2:279‑84.
J Endod 2002;28:322‑3. 23. Akca EA, Yildirim E, Dalkiz M, Yavuzyilmaz H, Beydemir B. Effects of
3. Azargoon H, Williams BJ, Solomon ES, Kessler HP, He J, Spears R, et al. different retraction medicaments on gingival tissue. Quintessence Int
Assessment of hemostatic efficacy and osseous wound healing using 2006;37:53‑9.
HemCon dental dressing. J Endod 2011;37:807‑11. 24. Tarighi P, Khoroushi M. A review on common chemical hemostatic
4. Fischer DE. Tissue management: A new solution to an old problem. Gen agents in restorative dentistry. Dent Res J (Isfahan) 2014;11:423‑8.
Dent 1987;35:178‑82. 25. Conrad HJ, Holtan JR. Internalized discoloration of dentin under
5. Lemon RR, Steele PJ, Jeansonne BG. Ferric sulfate hemostasis: Effect porcelain crowns: A clinical report. J Prosthet Dent 2009;101:153‑7.
on osseous wound healing. 1. left in situ for maximum exposure. 26. Land MF, Rosenstiel SF, Sandrik JL. Disturbance of the dentinal smear
J Endod 1993;19:170‑3. layer by acidic hemostatic agents. J Prosthet Dent 1994;72:4‑7.
6. Larson PO. Topical hemostatic agents for dermatologic surgery. 27. O’Keefe KL, Pinzon LM, Rivera B, Powers JM. Bond strength of composite
J Dermatol Surg Oncol 1988;14:623‑32. to astringent‑contaminated dentin using self‑etching adhesives. Am J
7. Palm MD, Altman JS. Topical hemostatic agents: A review. Dermatol Dent 2005;18:168‑72.
Surg 2008;34:431‑45. 28. Kuphasuck W, Harnirattisai C, Senawongse P, Tagami J. Bond strength
8. Amazon K, Robinson MJ, Rywlin AM. Ferrugination caused by of two adhesive systems to dentin contaminated with a hemostatic
Monsel’s solution. Clinical observations and experimentations. Am J agent. Oper Dent 2007;32:399‑405.
Dermatopathol 1980;2:197‑205. 29. Sharma V, Nainan MT, Shivanna V. The effect of cavity disinfectants on
9. Armstrong RB, Nichols J, Pachance J. Punch biopsy wounds treated the sealing ability of dentin bonding system: An in vitro study. J Conserv
with monsel’s solution or a collagen matrix. A comparison of healing. Dent 2009;12:109‑13.
Arch Dermatol 1986;122:546‑9. 30. Prabhakar AR, Bedi S. Effect of glutaraldehyde and ferric sulfate on
10. Olmstead PM, Lund HZ, Leonard DD. Monsel’s solution: A histoologic shear bond strength of adhesives to primary dentin. J Indian Soc Pedod
nuisance. J Am Acad Dermatol 1980;3:492‑8. Prev Dent 2008;26 Suppl 3:S109‑13.
11. Casas MJ, Kenny DJ, Johnston DH, Judd PL. Long‑term outcomes of 31. Ebrahimi SF, Shadman N, Abrishami A. Effect of ferric sulfate
primary molar ferric sulfate pulpotomy and root canal therapy. Pediatr contamination on the bonding effectiveness of etch‑and‑rinse and
Dent 2004;26:44‑8. self‑etch adhesives to superficial dentin. J Conserv Dent 2013;16:126‑30.
12. Fei AL, Udin RD, Johnson R. A clinical study of ferric sulfate as a 32. Harnirattisai C, Kuphasuk W, Senawongse P, Tagami J. Bond strengths
pulpotomy agent in primary teeth. Pediatr Dent 1991;13:327‑32. of resin cements to astringent‑contaminated dentin. Oper Dent
13. Fuks AB, Holan G, Davis JM, Eidelman E. Ferric sulfate versus dilute 2009;34:415‑22.
formocresol in pulpotomized primary molars: Long‑term follow up. 33. Anil A, Sekhar A, Thomas MS, Ginjupalli K. Haemostatic agents
Pediatr Dent 1997;19:327‑30. on the shear bond strength of self‑adhesive resin. J Clin Exp Dent
14. Christensen GJ, Christensen R. Astringedent by ultradent. Clin Res 2015;7:e356‑60.
Assoc Newsletter 1979;3:2. 34. Prasad KD, Hegde C, Agrawal G, Shetty M. Gingival displacement in
15. von Arx T, Jensen SS, Hänni S, Schenk RK. Haemostatic agents used in prosthodontics: A critical review of existing methods. J Interdis Dent
periradicular surgery: An experimental study of their efficacy and tissue 2011;1:80‑6.
reactions. Int Endod J 2006;39:800‑8. 35. Wassell RW, Barker D, Walls AW. Crowns and other extracoronal
16. Schröder U. Effect of an extra‑pulpal blood clot on healing following restorations: Impression materials and technique. Br Dent J
experimental pulpotomy and capping with calcium hydroxide. Odontol 2002;192:679‑84, 687‑90.
Revy 1973;24:257‑68. 36. Shaw DH, Krejci RF, Kalkwarf KL, Wentz FM. Gingival response to
17. Havale R, Anegundi RT, Indushekar K, Sudha P. Clinical and retraction by ferric sulfate (Astringedent). Oper Dent 1983;8:142‑7.
radiographic evaluation of pulpotomies in primary molars with 37. McCormick NJ, Moore UJ, Meechan JG. Haemostasis. Part 1:
formocresol, glutaraldehyde and ferric sulphate. Oral Health Dent The management of post‑extraction haemorrhage. Dent Update
Manag 2013;12:24‑31. 2014;41:290‑2, 294‑6.
18. Ranly DM. Pulpotomy therapy in primary teeth: New modalities for old 38. Jang Y, Kim H, Roh BD, Kim E. Biologic response of local hemostatic
rationales. Pediatr Dent 1994;16:403‑9. agents used in endodontic microsurgery. Restor Dent Endod
19. Landau MJ, Johnsen DC. Pulpal responses to ferric sulfate in monkeys. 2014;39:79‑88.
J Dent Res 1988;67:215. 39. Maestre‑Ferrin L, Penarrocha‑Diago M. Hemostatic agents used in
20. Cinar C, Odabaş ME, Akca G, Işik B. Antibacterial effect of a apical surgery: A review. J Clin Exp Dent 2011;3:e310‑3.
new haemostatic agent on oral microorganisms. J Clin Exp Dent 40. Kim S, Kratchman S. Modern endodontic surgery concepts and practice:
2012;4:e151‑5. A review. J Endod 2006;32:601‑23.
21. Rosenstiel SF. Tissue management and impression making. In: 41. Jeansonne BG, Boggs WS, Lemon RR. Ferric sulfate hemostasis: Effect
Rosenstiel SF, Land M and Fujimoto J. editors. Contemporary Fixed on osseous wound healing. II. With curettage and irrigation. J Endod
Prosthodontics. 4th ed. St. Louis, MO: Mosby‑Elsevier; 2006. p. 431‑65. 1993;19:174‑6.